当前位置: 首页 > 期刊 > 《中国实用医药》 > 2007年第33期
编号:11798267
干细胞在治疗心血管疾病中的研究进展(2)
http://www.100md.com 2009年10月6日 《中国实用医药》 2007年第33期
     5Orlic D, Kajstura J, Chimenti S. Bone marrow cells regenerate infracted myocardium. Nature, 2001,410: 701-705.

    6Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 1995, 18(12): 1417-1426.

    7Makino S, Fukuda K, Miyoshi S. Cardiomyocytes can be generated from marrow stromal cells in vivo. J Clin Invest, 1999, 103(5): 697-705.

    8Wang JS, Shum-Tim D, Galipeau J. Marrow stromal cells for cellular cardiomyoplasty.feasibility and potential clinical advantages. J Thorac Cardiovasc Surg, 2000, 120(5): 999-1005.

    9Mangi AA, Noiseux N, Kong D. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med,2003 ,9(9): 1195-2001.

    10Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis .Science, 1997, 275(5320): 964-967.

    11Maeda M, Fukui A, Nakamura T. Progenitor endothelial cells on vascular grafts.An ultrastructural study. J Biomed Mater Res, 2000, 51(1): 55-60.

    12Strauer BE, Brehm M, Zeus T . Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 2002, 106 (15): 1913- 1918.

    13Perin EC, Dohmann HF, Borojevic R. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 2003, 107(18): 2294-2302., http://www.100md.com(彭岚刚 刘成珪)
上一页1 2